Skip to main content

Want a detailed portfolio tracker?

Exelixis (EXEL) P/E (2011 - 2026)

Exelixis (EXEL) P/E from Sep 30, 2011 to Jul 21, 2026. The TTM Exelixis (EXEL) P/E is 17.72. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Exelixis (EXEL)

YearP/EChange
202617.72+0.37%
202517.65-14.42%
202420.63-43.05%
202336.21+28.14%
202228.26+12.80%
202125.06-37.92%
202040.36+365.92%
20198.66+1.69%
20188.52-85.61%
201759.19-340.61%
2016-24.60+234.50%
2015-7.35+583.86%
2014-1.08-77.31%
2013-4.74-9.58%
2012-5.24-166.75%
20117.85N/A

Comparison Exelixis (EXEL) P/E with competitors

Exelixis (EXEL) P/E is 17.72.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.99%
NBYStablecoin Development Corp0.00-99.98%
ENLVEnlivex Ltd0.07-99.58%
FGENFibroGen Inc0.24-98.65%
CHRSCoherus Biosciences Inc0.85-95.21%
FBIOFortress Biotech Inc0.95-94.64%
ORMPOramed Pharmaceuticals Inc1.50-91.52%
AGENAgenus Inc3.01-83.01%
INVAInnoviva Inc3.15-82.20%
VXRTVaxart Inc3.55-79.97%
CRMDCorMedix Inc3.63-79.52%
CVACCureVac N.V.4.45-74.91%
GLPGGalapagos NV4.86-72.58%
SRPTSarepta Therapeutics Inc4.88-72.45%
ABEOAbeona Therapeutics Inc5.39-69.59%
ABUSArbutus Biopharma Corp5.60-68.42%
ZVRAZevra Therapeutics Inc5.89-66.77%
SPROSpero Therapeutics Inc6.23-64.85%
CGENCompugen Ltd6.31-64.36%
RIGLRigel Pharmaceuticals6.87-61.21%
SLXNSilexion Therapeutics Corp7.30-58.82%
OMEROmeros Corporation9.26-47.74%
AUPHAurinia Pharmaceuticals Inc9.58-45.90%
PLXProtalix BioTherapeutics Inc10.89-38.53%
ACADAcadia Pharmaceuticals Inc11.73-33.80%
TBPHTheravance Biopharma Inc12.26-30.79%
ADMAAdma Biologics Inc12.42-29.91%
HRMYHarmony Biosciences Holdings Inc13.82-22.00%
SABSSAB Biotherapeutics Inc14.14-20.21%
NAGENiagen Bioscience Inc14.82-16.37%
INCYIncyte Corp15.82-10.70%
REGNRegeneron Pharmaceuticals Inc15.86-10.50%
PBYIPuma Biotechnology Inc17.32-2.27%
CPRXCatalyst Pharmaceuticals Inc17.44-1.57%
TGTXTG Therapeutics Inc18.97+7.05%
MDXGMimedx Group Inc20.55+16.00%
XOMAXOMA Royalty Corp22.87+29.11%
ARGXArgen X SE24.30+37.14%
CTMXCytomX Therapeutics Inc24.82+40.10%
XOMAOXOMA Royalty Corp25.34+43.05%
HALOHalozyme Therapeutics Inc25.62+44.63%
XOMAPXOMA Royalty Corp25.67+44.89%
VRTXVertex Pharmaceuticals Inc27.99+58.01%
RPRXRoyalty Pharma plc - Class A28.69+61.92%
SLNOSoleno Therapeutics Inc29.02+63.77%
ASNDAscendis Pharma A/S30.09+69.81%
LGNDLigand Pharmaceuticals Inc - Class B37.91+113.98%
APLSApellis Pharmaceuticals Inc39.02+120.24%
BMRNBiomarin Pharmaceutical Inc42.21+138.25%
KRYSKrystal Biotech Inc45.34+155.93%
ONCBeiGene Ltd69.54+292.50%
PHARPharming Group N.V.75.03+323.46%
TECHBio-Techne Corp101.96+475.47%
VCELVericel Corp109.92+520.42%
ALNYAlnylam Pharmaceuticals Inc117.96+565.82%
GMABGenmab140.29+691.83%
TLXTelix Pharmaceuticals Ltd162.15+815.22%
CORTCorcept Therapeutics Inc212.86+1101.41%